Extracts of fetal (20 days gestation) brain, heart, end liver were eva
luated for naltrexone in rats 1 hour following maternal injection of 5
0 mg/kg opioid antagonist; adult plasma from the pregnant rats was ana
lyzed. Samples were prepared by ultrafiltration, lyophilized, reconsti
tuted in mobile phase, and separated by reversed phase high-performanc
e liquid chromatography with ultraviolet detection. This qualitative a
nalysis revealed the presence of naltrexone in all fetal tissues, as w
ell as in adult plasma. These results indicate naltrexone, maternally
administered, passes through the placenta and enters the fetus. The da
ta would suggest that reports concerning somatic and neurobiological a
cceleration in offspring exposed to naltrexone during gestation, may b
e the result of a direct opioid antagonist action in the fetus.